Chemoinformaics analysis of C POLYGALAXANTHONE-A
| Molecular Weight | 330.292 | nRot | 3 |
| Heavy Atom Molecular Weight | 316.18 | nRig | 21 |
| Exact Molecular Weight | 330.074 | nRing | 4 |
| Solubility: LogS | -4.393 | nHRing | 2 |
| Solubility: LogP | 2.736 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 16 |
| nHA | 7 | APOL | 43.3391 |
| nHD | 0 | BPOL | 25.3289 |
| QED | 0.683 |
| Synth | 2.429 |
| Natural Product Likeliness | 0.998 |
| NR-PPAR-gamma | 0.025 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.94 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.689 |
| MDCK | 0.0000558 |
| BBB | 0.247 |
| PPB | 0.774404 |
| VDSS | 0.902 |
| FU | 0.169234 |
| CYP1A2-inh | 0.685 |
| CYP1A2-sub | 0.967 |
| CYP2c19-inh | 0.883 |
| CYP2c19-sub | 0.822 |
| CYP2c9-inh | 0.654 |
| CYP2c9-sub | 0.919 |
| CYP2d6-inh | 0.44 |
| CYP2d6-sub | 0.902 |
| CYP3a4-inh | 0.851 |
| CYP3a4-sub | 0.457 |
| CL | 5.854 |
| T12 | 0.268 |
| hERG | 0.159 |
| Ames | 0.601 |
| ROA | 0.107 |
| SkinSen | 0.512 |
| Carcinogencity | 0.884 |
| EI | 0.46 |
| Respiratory | 0.475 |
| NR-Aromatase | 0.704 |
| Antiviral | Yes |
| Prediction | 0.703685 |